We’ve recently updated our valuation analysis.

Far East Horizon Valuation

Is 3360 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3360?

Other financial metrics that can be useful for relative valuation.

3360 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio0.5x

Price to Earnings Ratio vs Peers

How does 3360's PE Ratio compare to its peers?

The above table shows the PE ratio for 3360 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average4.3x
1606 China Development Bank Financial Leasing
3.7x13.8%HK$13.7b
2666 Genertec Universal Medical Group
4.3x12.0%HK$8.9b
3877 CSSC (Hong Kong) Shipping
5x12.4%HK$8.4b
1905 Haitong Unitrust International Financial Leasing
4.2xn/aHK$6.8b
3360 Far East Horizon
4.3x8.8%HK$28.9b

Price-To-Earnings vs Peers: 3360 is good value based on its Price-To-Earnings Ratio (4.3x) compared to the peer average (4.3x).


Price to Earnings Ratio vs Industry

How does 3360's PE Ratio compare vs other companies in the Asian Diversified Financial Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.9%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.9%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 3360 is good value based on its Price-To-Earnings Ratio (4.3x) compared to the Asian Diversified Financial industry average (17.7x)


Price to Earnings Ratio vs Fair Ratio

What is 3360's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3360 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.3x
Fair PE Ratio8.6x

Price-To-Earnings vs Fair Ratio: 3360 is good value based on its Price-To-Earnings Ratio (4.3x) compared to the estimated Fair Price-To-Earnings Ratio (8.6x).


Share Price vs Fair Value

What is the Fair Price of 3360 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3360 (HK$6.7) is trading below our estimate of fair value (HK$24.06)

Significantly Below Fair Value: 3360 is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3360 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$6.70
HK$10.47
+56.2%
15.3%HK$12.47HK$7.31n/a9
Jun ’24HK$6.58
HK$10.47
+59.1%
15.3%HK$12.47HK$7.31n/a9
May ’24HK$7.05
HK$10.49
+48.8%
15.3%HK$12.50HK$7.32n/a9
Apr ’24HK$7.06
HK$10.49
+48.6%
15.3%HK$12.50HK$7.32n/a9
Mar ’24HK$7.08
HK$10.83
+53.0%
15.8%HK$12.49HK$7.32n/a8
Feb ’24HK$7.03
HK$10.72
+52.5%
16.9%HK$12.46HK$7.30n/a7
Jan ’24HK$6.10
HK$10.58
+73.4%
16.7%HK$12.41HK$7.27n/a7
Dec ’23HK$6.08
HK$10.59
+74.2%
16.6%HK$12.43HK$7.29n/a7
Nov ’23HK$5.83
HK$11.22
+92.4%
11.1%HK$12.50HK$9.00n/a6
Oct ’23HK$5.30
HK$11.22
+111.7%
11.1%HK$12.50HK$9.00n/a6
Sep ’23HK$5.69
HK$11.39
+100.1%
10.9%HK$12.50HK$9.00n/a6
Aug ’23HK$6.39
HK$11.35
+77.6%
9.0%HK$12.50HK$9.80n/a5
Jul ’23HK$6.58
HK$11.35
+72.5%
9.0%HK$12.50HK$9.80n/a5
Jun ’23HK$7.05
HK$11.35
+61.0%
9.0%HK$12.50HK$9.80HK$6.585
May ’23HK$6.41
HK$11.44
+78.5%
9.6%HK$12.51HK$9.80HK$7.055
Apr ’23HK$7.20
HK$11.65
+61.8%
9.5%HK$12.65HK$9.80HK$7.066
Mar ’23HK$6.72
HK$12.00
+78.6%
6.2%HK$12.63HK$10.50HK$7.086
Feb ’23HK$6.67
HK$11.98
+79.6%
6.1%HK$12.60HK$10.52HK$7.036
Jan ’23HK$6.92
HK$11.96
+72.8%
5.8%HK$12.54HK$10.53HK$6.106
Dec ’22HK$6.91
HK$11.93
+72.7%
5.8%HK$12.51HK$10.50HK$6.086
Nov ’22HK$7.46
HK$11.93
+59.9%
5.8%HK$12.51HK$10.50HK$5.836
Oct ’22HK$7.90
HK$11.72
+48.3%
5.9%HK$12.53HK$10.53HK$5.306
Sep ’22HK$8.99
HK$11.66
+29.7%
5.7%HK$12.52HK$10.52HK$5.697
Aug ’22HK$8.29
HK$11.17
+34.8%
7.7%HK$12.51HK$9.82HK$6.398
Jul ’22HK$8.12
HK$11.18
+37.7%
7.6%HK$12.50HK$9.81HK$6.588
Jun ’22HK$8.32
HK$11.18
+34.4%
7.6%HK$12.50HK$9.81HK$7.058

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies